SCM
Sio Capital Management Portfolio holdings
AUM
$249M
This Quarter Return
-3.08%
1 Year Return
+117.71%
3 Year Return
+238.99%
5 Year Return
+411.91%
10 Year Return
+912.87%
AUM
$248M
AUM Growth
+$248M
(-24%)
Cap. Flow
-$63.4M
Cap. Flow
% of AUM
-25.57%
Top 10 Holdings %
Top 10 Hldgs %
55.96%
Holding
84
New
11
Increased
11
Reduced
16
Closed
17
Top Buys
| 1 |
Labcorp
LH
|
$13M |
| 2 |
Sanofi
SNY
|
$10.9M |
| 3 |
Inogen
INGN
|
$10.1M |
| 4 |
Varex Imaging
VREX
|
$6.72M |
| 5 |
Medpace
MEDP
|
$4.65M |
Top Sells
| 1 |
Cardinal Health
CAH
|
$17.3M |
| 2 |
SPDR Gold Trust
GLD
|
$15.4M |
| 3 |
Cigna
CI
|
$12.8M |
| 4 |
Herbalife
HLF
|
$9.88M |
| 5 |
Galapagos
GLPG
|
$7.11M |
Sector Composition
| 1 | Healthcare | 89.58% |
| 2 | Financials | 9.16% |
| 3 | Consumer Staples | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MSAC
1
DELISTED
Medicus Sciences Acquisition Corp. Class A Ordinary Share
MSAC
| $22.7M | 7.52% | 2,323,000 | – | – |
|
|
2
Cigna
CI
$80.3B
| $16.3M | 5.38% | 67,830 -53,500 | -44% | -$12.8M |
|
3
Merck
MRK
$210B
| $16M | 5.3% | 195,160 -38,501 | -16% | -$3.16M |
|
|
4
Sanofi
SNY
$121B
| $15.4M | 5.1% | 300,000 +211,751 | +240% | +$10.9M |
|
|
5
Labcorp
LH
$23.1B
| $13M | 4.3% | +49,328 | New | +$13M |
|
|
6
Inogen
INGN
$216M
| $13M | 4.29% | 400,086 +311,795 | +353% | +$10.1M |
|
7
Cencora
COR
$56.5B
| $12.9M | 4.26% | 83,271 -14,169 | -15% | -$2.19M |
|
8
McKesson
MCK
$85.4B
| $10.6M | 3.49% | 34,501 -22,555 | -40% | -$6.9M |
|
9
United Therapeutics
UTHR
$13.8B
| $9.92M | 3.28% | 55,262 +2,069 | +4% | +$371K |
|
|
10
Galapagos
GLPG
$2.07B
| $9.1M | 3.01% | 146,696 -114,681 | -44% | -$7.11M |
|
11
Centene
CNC
$14.3B
| $8.15M | 2.69% | 96,762 -29,017 | -23% | -$2.44M |
|
|
12
Varex Imaging
VREX
$480M
| $6.72M | 2.22% | +315,486 | New | +$6.72M |
|
13
Ionis Pharmaceuticals
IONS
$6.79B
| $6.5M | 2.15% | 175,568 -146,998 | -46% | -$5.44M |
|
|
NTUS
14
DELISTED
Natus Medical Inc
NTUS
| $5.03M | 1.67% | 191,564 +83,869 | +78% | +$2.2M |
|
|
VAPO
15
DELISTED
Vapotherm, Inc. Common Stock
VAPO
| $4.91M | 1.62% | 353,006 +172,989 | +96% | +$2.4M |
|
|
16
Medpace
MEDP
$13.4B
| $4.65M | 1.54% | +28,400 | New | +$4.65M |
|
17
Curis
CRIS
$20.9M
| $4.56M | 1.51% | 1,915,460 -1,951,185 | -50% | -$4.64M |
|
|
ALBO
18
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
| $4.31M | 1.43% | 144,546 -69,367 | -32% | -$2.07M |
|
|
NARI
19
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $3.65M | 1.21% | +40,210 | New | +$3.65M |
|
20
Mirum Pharmaceuticals
MIRM
$3.71B
| $3.55M | 1.17% | 161,285 -109,029 | -40% | -$2.4M |
|
21
Xenon Pharmaceuticals
XENE
$2.98B
| $3.23M | 1.07% | +105,756 | New | +$3.23M |
|
|
RCOR
22
DELISTED
Renovacor, Inc.
RCOR
| $3.12M | 1.03% | 735,908 | – | – |
|
|
PNT
23
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $3.01M | 1% | 377,684 | – | – |
|
24
Viking Therapeutics
VKTX
$3.04B
| $3M | 0.99% | 999,829 +339,016 | +51% | +$1.02M |
|
|
AFMD
25
DELISTED
Affimed
AFMD
| $2.81M | 0.93% | +643,664 | New | +$2.81M |
|